We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
51
SLB Ltd
SLB
$72.7B
$2.65M 0.55%
29,927
– –
MGM icon
52
MGM Resorts International
MGM
$11.7B
$2.54M 0.52%
124,050
+700
+0.6% +$12.2K
OKS
53
DELISTED
Oneok Partners LP
OKS
$2.5M 0.52%
47,250
-675
-1% -$34.2K
T icon
54
AT&T
T
$164B
$2.44M 0.5%
95,496
+63
+0.1% +$1.65K
WFC icon
55
Wells Fargo
WFC
$254B
$2.39M 0.5%
57,920
– –
GS icon
56
Goldman Sachs
GS
$289B
$2.39M 0.49%
15,086
– –
MET icon
57
MetLife
MET
$62.4B
$2.36M 0.49%
56,351
+336
+0.6% +$14.5K
BXP icon
58
Boston Properties
BXP
$11.6B
$2.32M 0.48%
21,675
+50
+0.2% +$5.29K
FDX icon
59
FedEx
FDX
$73B
$2.27M 0.47%
19,930
+500
+3% +$54K
FCX icon
60
Freeport-McMoran
FCX
$86.2B
$2.27M 0.47%
68,708
+5,466
+9% +$167K
QQQ icon
61
Invesco QQQ Trust
QQQ
$436B
$2.2M 0.45%
27,857
-140
-0.5% -$10.7K
PAA icon
62
Plains All American Pipeline
PAA
$17.6B
$2.09M 0.43%
39,700
– –
MO icon
63
Altria Group
MO
$125B
$2.03M 0.42%
59,089
+5
+0% +$176
MON
64
DELISTED
Monsanto Co
MON
$2M 0.41%
19,193
– –
LLY icon
65
Eli Lilly
LLY
$1.08T
$1.92M 0.4%
38,200
– –
IYG icon
66
iShares US Financial Services ETF
IYG
$2.13B
$1.88M 0.39%
76,170
+3,930
+5% +$98.4K
EOG icon
67
EOG Resources
EOG
$77.7B
$1.85M 0.38%
21,880
+200
+0.9% +$15.5K
AXP icon
68
American Express
AXP
$224B
$1.83M 0.38%
24,232
-100
-0.4% -$7.52K
KRFT
69
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$1.82M 0.38%
34,702
-66
-0.2% -$3.62K
D icon
70
Dominion Energy
D
$62.1B
$1.8M 0.37%
28,841
– –
HD icon
71
Home Depot
HD
$337B
$1.79M 0.37%
23,660
+152
+0.6% +$11.7K
CVS icon
72
CVS Health
CVS
$135B
$1.72M 0.36%
30,332
-50
-0.2% -$2.98K
MDLZ icon
73
Mondelez International
MDLZ
$82.9B
$1.67M 0.35%
53,132
– –
WMB icon
74
Williams Companies
WMB
$85.8B
$1.59M 0.33%
43,740
+504
+1% +$17.7K
ET icon
75
Energy Transfer Partners
ET
$69.5B
$1.58M 0.33%
95,860
– –
1 2
3
4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.